Penumbra (PEN) Research & Development (2014 - 2026)
Penumbra's (PEN) quarterly Research & Development came in at $22.4 million in Q1 2026, up 1.38% year-on-year from $22.1 million in Q1 2025, and up 2.7% on a QoQ basis from $21.8 million in Q4 2025.
Penumbra (PEN) Research & Development (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Research & Development data on file, last reported at $22.4 million in Q1 2026.
- On a quarterly basis, Research & Development rose 1.38% year-over-year to $22.4 million in Q1 2026; TTM through Mar 2026 was $90.1 million, a 2.35% decrease from a year earlier, with the FY2025 full-year figure at $89.8 million, down 5.29% from the prior year.
- Research & Development for Q1 2026 stood at $22.4 million, up from $21.8 million in the prior quarter.
- Over the last five years, Research & Development for PEN reached as high as $25.2 million in Q3 2024 and fell as low as $18.0 million in Q4 2022.
- Historically, Research & Development has averaged $21.8 million across 5 years, with a median of $21.8 million in 2025.
- On a YoY basis, Research & Development climbed as much as 27.41% in 2022 and fell as far as 65.46% in 2022.
- Year by year, Research & Development stood at $18.0 million in 2022, then rose by 22.14% to $21.9 million in 2023, then slipped by 8.81% to $20.0 million in 2024, then advanced by 8.92% to $21.8 million in 2025, then gained by 2.7% to $22.4 million in 2026.
- Per Business Quant data, the three most recent Research & Development figures were $22.4 million in Q1 2026, $21.8 million in Q4 2025, and $22.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn | 22.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.38 Mn |
| Dec 31, 2025 | 21.79 Mn |
| Sep 30, 2025 | 22.68 Mn |
| Jun 30, 2025 | 23.22 Mn |
| Mar 31, 2025 | 22.08 Mn |
| Dec 31, 2024 | 20.01 Mn |
| Sep 30, 2024 | 25.21 Mn |
| Jun 30, 2024 | 24.94 Mn |
| Mar 31, 2024 | 24.63 Mn |
| Dec 31, 2023 | 21.94 Mn |
| Sep 30, 2023 | 20.96 Mn |
| Jun 30, 2023 | 21.54 Mn |
| Mar 31, 2023 | 19.99 Mn |
| Dec 31, 2022 | 17.96 Mn |
| Sep 30, 2022 | 21.32 Mn |
| Jun 30, 2022 | 19.56 Mn |
| Mar 31, 2022 | 20.56 Mn |
| Dec 31, 2021 | 52.00 Mn |
| Sep 30, 2021 | 16.73 Mn |
| Jun 30, 2021 | 17.74 Mn |